Thermo Fisher Establishes Personalised Medicine Research Center

BMI Core View: Personalised medicines will play a greater role in the treatment of patients. They offer fewer side-effects and treat illnesses more efficiently than wide-spectrum therapeutics. Smaller patient populations are a fundamental roadblock to the development of personalised medicine, but we believe this will be overcome by advanced cost-effectiveness studies in support of regulatory submissions. This should enable drugmakers to command much higher prices for personalised

To read the full article, please choose one of the following options: